AUTHORIZED USE
The FDA has authorized the emergency use of PAXLOVID, an investigational medicine, for the treatment of mild-to-moderate COVID-19 in adults and children (12 years of age and older weighing at least 88 pounds [40 kg]) with a positive test for the virus that causes COVID-19, and who are at high risk for progression to severe COVID-19, including hospitalization or death, under an EUA.
PAXLOVID is investigational because it is still being studied. There is limited information about the safety and effectiveness of using PAXLOVID to treat people with mild-to-moderate COVID-19.
Test-to-Treat* can help you get tested for COVID-19 and, if appropriate, receive treatment all in the same location.
*This link will take you to a website that is owned and operated by HHS. Pfizer is not responsible for the content or services of this site.
Test-to-Treat* can help you get tested for COVID-19 and, if appropriate, receive treatment all in the same location.
*These links will take you to a website that is owned and operated by HHS. Pfizer is not responsible for the content or services of this site.
Menu
Menu
Home
How to Take
Possible Side Effects
Frequently Asked Questions
Resources
Contact One of the Following Groups
For Medical Information visit www.pfizermedicalinformation.com or call 1-800-438-1985
For General Product Inquiries call 1‑877‑C19PACK (1-877-219-7225)
AUTHORIZED USE
The FDA has authorized the emergency use of PAXLOVID, an investigational medicine, for the treatment of mild-to-moderate COVID-19 in adults and children (12 years of age and older weighing at least 88 pounds [40 kg]) with a positive test for the virus that causes COVID-19, and who are at high risk for progression to severe COVID-19, including hospitalization or death, under an EUA.
PAXLOVID is investigational because it is still being studied. There is limited information about the safety and effectiveness of using PAXLOVID to treat people with mild-to-moderate COVID-19.
IMPORTANT SAFETY INFORMATION